Contact
Please use this form to send email to PR contact of this press release:
Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with Vitiligo
TO:
Please use this form to send email to PR contact of this press release:
Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with Vitiligo
TO: